E-LIB Suche - Ergebnisse für: Oluwole, Olalekan

1

Outpatient CAR T-Cell Therapy as Standard of Care: Current ..:

Gatwood, Katie ; Mahmoudjafari, Zahra ; Baer, Brittney...
Clinical Hematology International. 6 (2024) 2 - p. , 2024

Link: https://doi.org/10.46989..

2

The Implementation of Chimeric Antigen Receptor (CAR) T-cel..:

Knight E, Tristan ; Oluwole, Olalekan ; Kitko, Carrie
Clinical Hematology International. 6 (2024) 1 - p. , 2024

Link: https://doi.org/10.46989..

3

Bridging therapy with axicabtagene ciloleucel for large B-c..:

Jain, Michael D. ; Jacobs, Miriam T. ; Gao, Feng...
Blood Advances. 8 (2024) 4 - p. 1042-1050 , 2024

Link: https://doi.org/10.1182/..

4

Managing Infection Complications in the Setting of Chimeric..:

Ahmed, Nausheen ; Oluwole, Olalekan ; Mahmoudjafari, Zahra..
Clinical Hematology International. 6 (2024) 2 - p. , 2024

Link: https://doi.org/10.46989..

5

P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEI..:

Munoz, Javier ; Locke, Frederick ; Lekakis, Lazaros...
HemaSphere. 7 (2023) S3 - p. e8808264 , 2023

Link: https://doi.org/10.1097/..

6

Relapsed or refractory large B‐cell lymphoma after chimeric..:

Del Toro‐Mijares, Raul ; Oluwole, Olalekan ; Jayani, Reena V....
British Journal of Haematology. 201 (2023) 1 - p. 15-24 , 2023

Link: https://doi.org/10.1111/..

7

ASTCT Clinical Practice Recommendations for Transplantation..:

Epperla, Narendranath ; Kumar, Ambuj ; Abutalib, Syed A....
Transplantation and Cellular Therapy. 29 (2023) 9 - p. 548-555 , 2023

Link: https://doi.org/10.1016/..

8

P1694: COST-EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL VS. TI..:

Oluwole, Olalekan ; Ray, Markqayne ; Davies, Neil...
HemaSphere. 7 (2023) S3 - p. e200756c , 2023

Link: https://doi.org/10.1097/..

9

Taking a BiTE out of the CAR T space race:

Patel, Ameet ; Oluwole, Olalekan ; Savani, Bipin.
British Journal of Haematology. 195 (2021) 5 - p. 689-697 , 2021

Link: https://doi.org/10.1111/..

10

CAR T cell therapy in solid tumors: A review of current cli..:

Patel, Urvi ; Abernathy, John ; Savani, Bipin N...
eJHaem. 3 (2021) S1 - p. 24-31 , 2021

Link: https://doi.org/10.1002/..

11

New targets for CAR T therapy in hematologic malignancies:

Savani, Malvi ; Oluwole, Olalekan ; Dholaria, Bhagirathbhai
Best Practice & Research Clinical Haematology. 34 (2021) 3 - p. 101277 , 2021

Link: https://doi.org/10.1016/..

12

Overview of approved CAR‐T therapies, ongoing clinical tria..:

Sengsayadeth, Salyka ; Savani, Bipin N. ; Oluwole, Olalekan.
eJHaem. 3 (2021) S1 - p. 6-10 , 2021

Link: https://doi.org/10.1002/..

13

High Sensitivity Troponin T and NT-proBNP in Patients Recei..:

Oluwole, Olalekan ; Moslehi, Javid J. ; Salem, Joe-Elie...
Clinical Hematology International. 3 (2021) 3 - p. 96 , 2021

Link: https://doi.org/10.2991/..

14

Updated Phase 1 Results of Zuma-3: Kte-X19, an Anti-CD19 Ch..:

Wierda, William G ; Bishop, Michael R. ; Oluwole, Olalekan...
Biology of Blood and Marrow Transplantation. 25 (2019) 3 - p. S185 , 2019

Link: https://doi.org/10.1016/..

15

2-Year Follow-up and High-Risk Subset Analysis of Zuma-1, t..:

Neelapu, Sattva S. ; Ghobadi, Armin ; Jacobson, Caron A....
Biology of Blood and Marrow Transplantation. 25 (2019) 3 - p. S65 , 2019

Link: https://doi.org/10.1016/..